Literature DB >> 7779348

Benefit-cost analysis of community residential versus institutional services for adults with severe mental retardation and challenging behaviors.

C A Knobbe1, S P Carey, L Rhodes, R H Horner.   

Abstract

A benefit-cost analysis was conducted to compare services in community residences versus an institution for 11 individuals with severe mental retardation and challenging behaviors who had been moved from an institution to a community setting. Effects that were not readily quantifiable in economic terms also were examined. Overall, the community-based program costs represented slight public savings over costs of the state institution. However, community living netted significant increases in variables such as resident's social networks, opportunities for integrated activities, and income.

Entities:  

Mesh:

Year:  1995        PMID: 7779348

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  4 in total

Review 1.  The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.

Authors:  M Deverill; J Brazier; C Green; A Booth
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

2.  A renaissance in residential behavior analysis? A historical perspective and a better way to help people with challenging behavior.

Authors:  S Holburn
Journal:  Behav Anal       Date:  1997

3.  Beyond mortality--residential placement and quality of life among children with mental retardation.

Authors:  M S Durkin
Journal:  Am J Public Health       Date:  1996-10       Impact factor: 9.308

4.  Developing and feasibility testing of data collection methods for an economic evaluation of a supported selfmanagement programme for adults with a learning disability and type 2 diabetes.

Authors:  John L O'Dwyer; Amy M Russell; Louise D Bryant; Rebecca E A Walwyn; Alexandra M Wright-Hughes; Elizabeth H Graham; Judy M Wright; Shaista Meer; Jacqueline Birtwistle; Amanda J Farrin; Allan O House; Claire T Hulme
Journal:  Pilot Feasibility Stud       Date:  2018-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.